Avalon Labs vs Venom — how do they compare? Avalon Labs trades at Rp287.69 (market cap Rp46,28M, Rp18,64M 24h volume), while Venom trades at Rp333.71 (market cap Rp340,86M, Rp2,89M 24h volume). The key difference: Venom is far larger — about 7.4× Avalon Labs's market cap, and Avalon Labs's circulating supply is 161,7M / 1B AVL (17%) versus 988,9M / 8B VENOM (13%) for Venom. Which is the better fit depends on your goals — on Pluang, investors hold Avalon Labs for 9 Days and Venom for 24 Days on average.
| AVL | VENOM | |
|---|---|---|
Market Cap | Rp46,28M | Rp340,86M |
Volume (24h) | Rp18,64M | Rp2,89M |
Circulating Supply | 161,7M / 1B AVL (17%) | 988,9M / 8B VENOM (13%) |
Typical Hold Time | 9 Days | 24 Days |
Signals from Pluang's Aura AI — not financial advice
AVL is trading at Rp286.54 with a bearish technical outlook, showing sell signals across moving averages while oscillators remain neutral. The token faces resistance at Rp288 with support at Rp280, indicating potential downside pressure. With only 17% of max supply circulating and average hold time of 9 days, liquidity remains limited. Recent news shows no direct crypto ecosystem developments for this token.
Overall outlook remains cautious with bearish technical momentum outweighing neutral oscillators. Key opportunity lies in potential breakout above Rp288 resistance, while major risks include low liquidity, limited circulation, and absence of recent protocol updates. Investors should monitor for any blockchain ecosystem developments that could drive adoption.
VENOM displays limited market activity with a modest market cap of Rp340.86M and only 13% of its maximum 8M token supply in circulation. The asset shows minimal trading volume and network activity, with an average hold time of 24 days indicating cautious investor behavior. No recent protocol updates or significant ecosystem developments have been observed, suggesting stagnant project growth.
Overall outlook remains cautious due to limited liquidity and adoption. Key opportunity lies in potential future protocol development, while major risks include extreme volatility from low market depth and regulatory uncertainty in the crypto space. Investors should monitor for any signs of renewed developer activity or exchange listings.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Avalon Labs is building an on-chain financial center for Bitcoin, offering solutions like BTC-backed lending, a Bitcoin-backed stablecoin, yield-generating accounts, and a credit card. Our goal is to create a scalable, transparent, and accessible financial network for Bitcoin holders to use Bitcoin as an economic asset. AVL is the governance token of the Avalon Labs ecosystem. We started as the world's largest issuer of Bitcoin-backed collateralized debt positions (CDPs) and have since expanded into DeFi lending, fixed-rate CeDeFi models, and stablecoins. This growth, driven by community demand, positions Avalon as a leader in on-chain finance. With AVL, we empower our community to actively shape the future of Avalon.
Read more on AVL →Venom is a Layer 0 and Layer 1 network built on mesh technology that supports large-scale platforms like stablecoins and CBDCs. Its high scalability, speed, and low fees make it ideal for Web3 dApps, ensuring security and stability for high-load systems.
Read more on VENOM →